Cite
HARVARD Citation
Ng, T. et al. (2019). Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer. Cancer. 125 (7), pp. 1038-1049. [Online].